1887

Abstract

The parvovirus PARV4 is the most recently described member of the family that has a human host. To investigate the prevalence of PARV4 in blood, a quantitative TaqMan PCR was developed and plasma, sera or whole blood from a variety of population groups were examined. Eight samples were positive for PARV4, one at high copy number. The high-titre-positive plasma had an approximate viral load of 5×10 genome equivalents ml. Two human sera, identified as PARV4 antibody-positive by indirect immunofluorescence, were used in immune electron microscopy to try to visualize native PARV4 within the high-titre human plasma. PARV4 particles were observed using one of these two sera. To our knowledge, this is the first time that native PARV4 has been visualized.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.014852-0
2010-02-01
2019-11-17
Loading full text...

Full text loading...

/deliver/fulltext/jgv/91/2/541.html?itemId=/content/journal/jgv/10.1099/vir.0.014852-0&mimeType=html&fmt=ahah

References

  1. Anderson, M. J., Jones, S. E., Fisher-Hoch, S. P., Lewis, E., Hall, S. M., Bartlett, C. L., Cohen, B. J., Mortimer, P. P. & Pereira, M. S. ( 1983; ). Human parvovirus, the cause of erythema infectiosum (fifth disease)? Lancet 1, 1378
    [Google Scholar]
  2. Candotti, D., Parsyan, A., Etiz, N. & Allain, J. P. ( 2004; ). Identification and characterisation of persistent human erythrovirus infection in blood donor samples. J Virol 78, 12169–12178.[CrossRef]
    [Google Scholar]
  3. Cossart, Y. E., Field, A. M., Cant, B. & Widdows, D. ( 1975; ). Parvovirus-like particles in human sera. Lancet 1, 72–73.
    [Google Scholar]
  4. Curry, A., Appleton, H. & Dowsett, B. ( 2006; ). Application of transmission electron microscopy to the clinical study of viral and bacterial infections: present and future. Micron 37, 91–106.[CrossRef]
    [Google Scholar]
  5. Fryer, J. F., Kapoor, A., Minor, P. D., Delwart, E. & Baylis, S. A. ( 2006; ). Novel parvovirus and related variant in human plasma. Emerg Infect Dis 12, 151–154.[CrossRef]
    [Google Scholar]
  6. Fryer, J. F., Delwart, E., Bernardin, F., Tuke, P. W., Lukashov, V. V. & Baylis, S. A. ( 2007a; ). Analysis of two human parvovirus PARV4 genotypes identified in human plasma for fractionation. J Gen Virol 88, 2162–2167.[CrossRef]
    [Google Scholar]
  7. Fryer, J. F., Delwart, E., Hecht, F. M., Bernardin, F., Jones, M. S., Shah, N. & Baylis, S. A. ( 2007b; ). Frequent detection of the parvoviruses, PARV4 and PARV5, in plasma from blood donors and symptomatic individuals. Transfusion 47, 1054–1061.[CrossRef]
    [Google Scholar]
  8. Hijikata, M., Abe, K., Win, K. M., Shimizu, Y. K., Keicho, N. & Yoshikura, H. ( 2001; ). Identification of new parvovirus DNA sequence in swine sera from Myanmar. Jpn J Infect Dis 54, 244–245.
    [Google Scholar]
  9. Jones, M. S., Kapoor, A., Lukashov, V. V., Simmonds, P., Hecht, F. & Delwart, E. ( 2005; ). New DNA viruses identified in patients with acute viral infection syndrome. J Virol 79, 8230–8236.[CrossRef]
    [Google Scholar]
  10. Lau, S. K., Woo, P. C., Tse, H., Fu, C. T., Au, W. K., Chen, X. C., Tsoi, H. W., Tsang, T. H., Chan, J. S. & other authors ( 2008; ). Identification of novel porcine and bovine parvoviruses closely related to human parvovirus 4. J Gen Virol 89, 1840–1848.[CrossRef]
    [Google Scholar]
  11. Lefrère, J. J., Servant-Delmas, A., Candotti, D., Mariotti, M., Thomas, I., Brossard, Y., Lefrère, F., Girot, R., Allain, J. P. & Laperche, S. ( 2005; ). Persisent B19 infection in immunocompetent individuals: implications for transfusion safety. Blood 106, 2890–2895.[CrossRef]
    [Google Scholar]
  12. Lurcharchaiwong, W., Chieochansin, T., Payungporn, S., Theamboonlers, A. & Poovorawan, Y. ( 2008; ). Parvovirus 4 (PARV4) in serum of intravenous drug users and blood donors. Infection 36, 488–491.[CrossRef]
    [Google Scholar]
  13. Manning, A., Willey, S. J., Bell, J. E. & Simmonds, P. ( 2007; ). Comparison of tissue distribution, persistence, and molecular epidemiology of parvovirus B19 and novel human parvoviruses PARV4 and human bocavirus. J Infect Dis 195, 1345–1352.[CrossRef]
    [Google Scholar]
  14. Norja, P., Hokynar, K., Aaltonen, L. M., Chen, R., Ranki, A., Partio, E. K., Kiviluoto, O., Davidkin, I., Leivo, T. & other authors ( 2006; ). Bioportfolio: lifelong persistence of variant and prototypic erythrovirus DNA genomes in human tissue. Proc Natl Acad Sci U S A 103, 7450–7453.[CrossRef]
    [Google Scholar]
  15. Schneider, B., Fryer, J. F., Oldenburg, J., Brackmann, H. H., Baylis, S. A. & Eis-Hubinger, A. M. ( 2008; ). Frequency of contamination of coagulation factor concentrates with novel human parvovirus PARV4. Haemophilia 14, 978–986.[CrossRef]
    [Google Scholar]
  16. Simmonds, P., Manning, A., Kenneil, R., Carnie, F. W. & Bell, J. E. ( 2007; ). Parenteral transmission of the novel human parvovirus PARV4. Emerg Infect Dis 13, 1386–1388.[CrossRef]
    [Google Scholar]
  17. Simmonds, P., Douglas, J., Bestetti, G., Longhi, E., Antinori, S., Parravicini, C. & Corbellino, M. ( 2008; ). A third genotype of the human parvovirus PARV4 in sub-Saharan Africa. J Gen Virol 89, 2299–2302.[CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.014852-0
Loading
/content/journal/jgv/10.1099/vir.0.014852-0
Loading

Data & Media loading...

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error